Filing Details
- Accession Number:
- 0000109657-11-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-19 20:34:32
- Reporting Period:
- 2010-12-23
- Filing Date:
- 2011-01-19
- Accepted Time:
- 2011-01-19 20:34:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 109657 | Oxis International Inc | OXIS.OB | Pharmaceutical Preparations (2834) | 941620407 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1223658 | Anshuman Dube | 2049 Century Park East Suite 3630 Los Angeles CA 90067 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-23 | 700,000 | $0.05 | 700,000 | No | 4 | C | Indirect | Theorem Group, LLC |
| Common Stock | Disposition | 2010-12-23 | 339,900 | $0.13 | 360,100 | No | 4 | S | Indirect | Theorem Group, LLC |
| Common Stock | Disposition | 2010-12-27 | 360,100 | $0.13 | 0 | No | 4 | S | Indirect | Theorem Group, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | Theorem Group, LLC |
| No | 4 | S | Indirect | Theorem Group, LLC |
| No | 4 | S | Indirect | Theorem Group, LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | 0% Convertible Debenture | Disposition | 2010-12-23 | 700,000 | $0.05 | 700,000 | $0.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,100,000 | 2009-10-01 | 2011-09-30 | No | 4 | C | Indirect |
Footnotes
- Sale of common stock acquired through partial conversion of underlying debenture.
- The reporting person is a managing director of Theorem Group, LLC. The reporting person disclaims beneficial ownership of the securities held by Theorem Group, LLC, except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
